GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. Their findings are found in two papers published today in the journal eLife.
“The genes we ‘knocked out’ using CRISPR/Cas9 resulted in markedly diminished symptoms of infection in our animal models,” said Paul Brindley, PhD, professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, and lead author. “Our research also showed that this revolutionary new biomedical procedure — CRISPR/Cas9 — can be adapted to study helminth parasites, which are a major public health problem in tropical climates.”
CRISPR/Cas9 is a new technology that allows researchers to precisely target and deactivate the genetic information needed to produce a particular protein. While the tool has been used in other species before, it was unknown if it could be applied to Schistosoma mansoni and Opisthorchis viverrini, the parasites responsible for schistosomiasis and liver fluke infection.
Schistosomiasis can cause serious health problems, including damage to the liver and kidneys, infertility and bladder cancer. The freshwater worms S. mansoni enter the human body by burrowing into the skin; once in the bloodstream, they move to various organs where they rapidly start to reproduce. Their eggs release several molecules, including a protein known as omega-1 ribonuclease, which can damage the surrounding tissues. Brindley and his research team “knocked out” this protein using CRISPR/Cas9 and found that it greatly reduced the impact of the disease.
Liver fluke infection can cause a type of liver cancer called bile duct cancer, triggered by the presence of the worm O. viverrini. This parasite is transmitted through traditional Southeast Asian cuisines using uncooked or undercooked fish. Once inside the body, the parasite settles in the human liver and secretes a protein known as granulin that may encourage liver cells to multiply, raising the risk for cancer. Brindley and his research team used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.
“These neglected tropical diseases affect more than a quarter of a billion people primarily living in Southeast Asia, sub-Saharan Africa, and Latin America,” said Brindley. “CRISPR/Cas9 is a tool that may be used to limit the impact of these infections. As we work to better understand how these parasites invade and damage our bodies through this new technology, we will find new ideas for treatment and disease control.”
Learn more: Gene-Editing Tool CRISPR/Cas9 Shown to Limit Impact of Certain Parasitic Diseases
The Latest on: CRISPR/Cas9
[google_news title=”” keyword=”CRISPR/Cas9″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: CRISPR/Cas9
- BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?on May 17, 2024 at 9:46 am
What’s the Difference? Bluebird Bio and CRISPR Therapeutics are frontrunners in gene editing, offering hope for patients battling blood disorders like sickle cell disease (SCD) and beta-thalassemia ...
- Scientist arrested for genetically editing babieson May 17, 2024 at 6:15 am
He claimed that he was attempting to prevent HIV in newborn babies. A Horrifying Announcement At a scientific conference in Hong Kong, Dr. He announced his successful attempt at genetically editing a ...
- How Gene Editing Therapies Could Go Beyond Rare Diseaseson May 16, 2024 at 6:00 am
In the wake of the first CRISPR medicine, scientists are working to develop gene editing therapies for diseases like cystic fibrosis, ALS and cardiovascular disease.
- New strategy suppresses unwanted deletion events to make genome editing safer and more preciseon May 15, 2024 at 10:19 am
A simple and robust strategy developed by KAUST scientists could help to improve the safety and accuracy of CRISPR gene editing, a tool that is already approved for clinical use for the treatment of ...
- CRISPR can treat common form of inherited blindness, early data hinton May 15, 2024 at 7:33 am
In a small trial, some people with inherited vision loss experienced improvements in their sight after being treated with CRISPR.
- CRISPR gene editing tool helps partially restore vision to blind patients in clinical trialson May 13, 2024 at 2:56 am
At the same time, a study conducted in 2021-2023 using the CRISPR gene editing tool showed promising results — the technology was used to correct th ...
- BSM arranges workshop on CRISPR-Cas9 Gene Editing: A new era in molecular biologyon May 12, 2024 at 3:36 am
Bangladesh Society of Microbiologists (BSM) arranged a comprehensive 5-day workshop providing hands-on training on CRISPR experimental design to 20 candidates in the first phase of the workshop ...
- How a CRISPR gene editing trial was able to treat some cases of inherited blindnesson May 9, 2024 at 1:24 am
Researchers have used a CRISPR-Cas9 tool to restore vision in a group of adults and children with congenital blindness.
- CRISPR Enzyme Found in Metagenomic Study Is Tiny, Yet Active and Preciseon May 6, 2024 at 6:30 pm
Metagenomic study uncovers previously uncharacterized Cas9 nucleases, including CoCas9, which is compact, but still active and precise.
- The CRISPR Battle Through the Lens of International Patent Harmonizationon May 6, 2024 at 1:40 pm
On Tuesday, May 7, the U.S. Court of Appeals for the Federal Circuit will hear argument in a long-awaited appeal addressing the inventorship of the Nobel Prize-winning CRISPR technology.
via Bing News